(Reuters) – CeriBell said on Wednesday it was targeting a valuation of as much as $578.3 million in its upsized initial public offering in the United States, indicating strong investor demand for the medical device maker.
The company is now aiming to raise as much as $180.3 million by offering about 10.6 million shares at $16 to $17 each.
CeriBell had earlier planned on offering 6.7 million shares priced between $14 and $16 each.
Certain existing shareholders have indicated an interest in purchasing up to about $40 million worth of CeriBell shares sold in the offering at the IPO price.
(Reporting by Arasu Kannagi Basil in Bengaluru; Editing by Shilpi Majumdar)
